Oluseyi Abidoye

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic in Florida · ORCID：0000-0002-5666-6085

发表论文 84 篇 · 总被引 177 次 · h-index 7

代表论文

Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab (2025 · European Journal of Cancer · 被引 3)
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience (2026 · JCO Precision Oncology · 被引 1)
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab (2026 · Targeted Oncology · 被引 1)
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting (2026 · International Journal of Cancer)
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab (2026 · International Journal of Cancer)